Coherence therapy criticism: an honest look
A balanced examination of the main criticisms of coherence therapy — limited clinical trials, broad claims, and the gap between neuroscience and clinical practice.
Any therapy worth taking seriously should be able to withstand honest criticism. Coherence therapy makes significant claims about the nature of emotional change — it should be held to a high standard. Here's a fair look at the main criticisms.
Why criticism matters
The therapy world is full of approaches that promise transformative results based on compelling theories. Some deliver; many don't. Critical evaluation protects both clients and the field. Coherence therapy advocates themselves emphasize the importance of empirically grounded practice — so holding the approach to that standard is appropriate.
Limited clinical trials
The criticism: Coherence therapy has not been tested in randomized controlled trials (RCTs). Its clinical evidence relies primarily on case studies and clinical observation. By the standards used to evaluate therapies like CBT, EMDR, or prolonged exposure, it doesn't qualify as "evidence-based."
The response: This is a legitimate limitation. Case studies, however detailed, can't control for placebo effects, therapist factors, or natural improvement. The coherence therapy community points to the strong neuroscience foundation — memory reconsolidation is well-replicated — but a gap remains between "the mechanism exists" and "this therapy reliably activates it."
Fair assessment: The absence of RCTs is a real weakness. It doesn't mean the therapy doesn't work, but it does mean we can't say with conventional confidence that it works better than alternatives or placebo. More research is needed — and the coherence therapy community acknowledges this.
Broad claims about other therapies
The criticism: Bruce Ecker and colleagues claim that whenever any therapy produces lasting transformational change, it's because the reconsolidation sequence was inadvertently carried out. This is a sweeping claim that's difficult to verify and could be seen as unfalsifiable — if change lasts, it was reconsolidation; if it doesn't, it wasn't.
The response: The claim is based on a logical argument: reconsolidation is the only known mechanism that erases (rather than suppresses) emotional learning, so lasting erasure of emotional responses must involve reconsolidation. Ecker has published detailed analyses mapping the reconsolidation sequence onto cases from EMDR, IFS, and other modalities.
Fair assessment: The argument is logically coherent but empirically unproven. It's difficult to verify that reconsolidation occurred in any specific therapy case without neuroimaging or other biological markers. The claim may be correct, but it currently rests on theoretical reasoning rather than direct evidence.
The lab-to-clinic gap
The criticism: Reconsolidation research is conducted in controlled laboratory conditions — specific stimuli, precise timing, measurable responses. A therapy session is vastly more complex. The emotional learnings targeted in therapy are more layered and harder to isolate than a conditioned fear response in a lab. Can reconsolidation really be "engineered" in such a complex environment?
The response: This is a fair concern. Coherence therapists would argue that the core requirements (reactivation + mismatch + repetition) are identifiable in clinical work, even if the content is more complex than lab paradigms. They also point to distinctive clinical markers — the sudden absence of a long-standing reaction, the "I can't find the feeling anymore" experience — as evidence that reconsolidation is occurring.
Fair assessment: The gap between lab conditions and clinical reality is real. It's plausible that reconsolidation occurs in therapy, but it's also plausible that what therapists interpret as reconsolidation involves other mechanisms. Until we have better ways to verify reconsolidation in clinical settings, this remains an open question.
Availability and access
The criticism: Coherence therapy practitioners are relatively rare. Training is offered primarily through the Coherence Psychology Institute. Finding a qualified therapist — especially in person — can be difficult. This limits who can actually benefit from the approach.
The response: This is an access problem, not a validity problem. Many coherence therapists now work online, expanding access. And the principles of coherence therapy can be integrated into other therapeutic frameworks — a therapist trained in another modality can learn to recognize and facilitate the reconsolidation sequence.
Fair assessment: A real practical limitation. See our training guide for information on how therapists can learn the approach.
The balanced view
Coherence therapy has genuine strengths: a clear theoretical framework grounded in neuroscience, a specific and testable model of how change works, and promising clinical observations. It also has genuine weaknesses: limited controlled research, broad claims that are hard to verify, and a small practitioner community.
The most intellectually honest position: coherence therapy is a promising approach with a strong theoretical foundation that needs more rigorous clinical research. It's not proven in the way CBT or EMDR are proven, but its theoretical basis gives it more scientific grounding than many less-studied approaches.
If you're considering coherence therapy, go in with open eyes. The theory is compelling, the clinical reports are encouraging, and the neuroscience is solid — but the gold-standard clinical evidence isn't there yet. For more context, see Is coherence therapy evidence-based?